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Reports differ regarding the effect of concomitant coronary artery bypass grafting (CABG)
in patients who undergo aortic valve replacement (AVR) for aortic stenosis (AS), and no
reports have described the effect of aortic valve structure in patients who undergo AVR for
AS. A total of 871 patients aged 24 to 94 years (mean 70) whose AVR for AS was their first
cardiac operation, with or without first concomitant CABG, were included. Patients who
underwent mitral valve procedures were excluded. In comparison with the 443 patients
(51%) who did not undergo CABG, the 428 (49%) who underwent concomitant CABG were
significantly older, were more often male, had lower transvalvular peak systolic pressure
gradients and larger valve areas, had lower frequencies of congenitally malformed aortic
valves, had lighter valves by weight, had higher frequencies of systemic hypertension, and
had longer stays in the hospital after AVR. Early and late (to 10 years) mortality were
similar by propensity-adjusted analysis in patients who did and did not undergo
concomitant CABG. Congenitally unicuspid or bicuspid valves occurred in approxi-
mately 90% of those aged 21 to 50, in nearly 70% in those aged 51 to 70 years, and in
just over 30% in those aged 71 to 95 years. Unadjusted and adjusted survival was
significantly higher in patients with unicuspid or bicuspid valves compared to those
with tricuspid valves. In conclusion, although concomitant CABG had no effect on the
adjusted probability of survival, the type of aortic valve (unicuspid or bicuspid vs
tricuspid) significantly affected the unadjusted and adjusted probability of
survival. © 2012 Elsevier Inc. All rights reserved. (Am J Cardiol 2012;109:1334–1340)Adults with isolated (no mitral valve disease) aortic
stenosis (AS) (with or without aortic regurgitation) fre-
quently have associated narrowing of 1 major (right, left
main, left anterior descending, or left circumflex) epicardial
coronary arteries. In reported patients who undergo aortic
valve replacement (AVR) for AS, the effect of concomitant
coronary artery bypass grafting (CABG) on early and late
mortality has been variable. The aim of this study was to
compare among patients with isolated AS the outcomes of
AVR in patients with versus without CABG and also the
effect of aortic valve structure (unicuspid or bicuspid vs
tricuspid) on the probability of long-term survival after
AVR for AS.
Methods
The surgical pathology files of the cardiovascular lab-
oratory, a part of the pathology department at Baylor
Departments of aInternal Medicine (Division of Cardiology), bPathol-
ogy, and cCardiothoracic Surgery and the dBaylor Heart and Vascular
Institute, Baylor University Medical Center; eInstitute for Health Care
Research and Improvement, Baylor Health Care System; fDepartment of
tatistical Science, Southern Methodist University, Dallas Texas; gUniver-
sity of Georgia, Athens, Georgia; and hUniversity of Texas at Austin,
Austin, Texas. Manuscript received December 5, 2011; revised manuscript
received and accepted December 8, 2011.
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0002-9149/12/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
doi:10.1016/j.amjcard.2011.12.028University Medical Center (BUMC) in Dallas, were
searched for patients having operatively excised aortic
valves without simultaneous replacement of the mitral
valve or evidence of mitral stenosis. From January 2002
through June 2010 (102 months [8.5 years]), a total of
1,040 operatively excised stenotic aortic valves were
submitted to the cardiovascular laboratory at BUMC.
Each was described, and the surgical report was prepared
by W.C.R. and photographed by J.M.K. The valve struc-
ture in each was determined by W.C.R from examination
of the operatively excised aortic valve. This study was
approved by the Institutional Review Board at BUMC on
May 5, 2010, and the requirement for individual patient
consent was waived.
Included in the present study were 871 adults whose
AVR for AS was their first cardiac operation, with or with-
out first simultaneous CABG. Patients who underwent iso-
lated AVR for AS and later in a second operation underwent
CABG or vice versa were excluded.
Clinical records, including admission note, discharge
summary, echocardiographic and cardiac catheterization re-
ports, and operative records, were sought from the patients’
medical charts and/or BUMC Apollo cardiovascular data-
base (Apollo Advance c/s version 4.2.13; LUMEDX Cor-
poration, Oakland, California). (The Apollo system became
operational at BUMC in January 2002.)
Echocardiographic and hemodynamic data were ob-
tained from the cardiovascular computer database.
Whether simultaneous CABG was performed at the time
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1335Valvular Heart Disease/Aortic Stenosis  Coronary Diseaseof AVR was also obtained from either the computer
database or from the medical records. Information re-
garding the death of any patient was obtained from 3
sources: (1) the medical records in the deaths during the
hospitalization at the time of AVR, (2) the Society of
Thoracic Surgeons National Database, and (3) the Social
Security Death Index for posthospitalization deaths.
Echocardiographic data preoperatively were available for
426 patients (49%). Cardiac catheterization data preop-
eratively were available for 561 patients (64%).
Means, standard deviations, and percentages were cal-
Table 1
Frequency of concomitant coronary artery bypass grafting in patients who
Variable
Age group (years)
21–50
51–70
71–95
Gender
Male
Female
Race
White
Black
Hispanic
Other or unknown
Number of major coronary arteries narrowed 50%
0
1
2
3
4
LV-aorta peak systolic gradient (mm Hg) (n  475),
range (mean) [median]
Aortic valve area (cm2) (n  474), mean  SD
ortic valve structure
Unicuspid
Bicuspid
Tricuspid
ortic valve weight (g)
Unicuspid, range (mean) [median] 1.
Bicuspid, range (mean) [median] 0.6
Tricuspid, range (mean) [median] 0.
Systemic hypertension by history
Body mass index (kg/m2)
25
25–30
30–40
40
Range (mean  SD)
ays in hospital postoperatively in patients living 30
days, range (mean) [median]
ied 30 days postoperatively
scending aorta replaced
mplanted valve type
Mechanical
Bioprosthetic
Ross procedure
* These patients had significant narrowing of a branch of 1 major coculated to describe the study cohort (n  871). Differ-ences in demographic, clinical, and morphologic details
were tested using Wilcoxon’s tests (for continuous vari-
ables) or chi-square tests (for categorical variables). Bon-
ferroni’s correction was used to account for multiplicity.
Unadjusted p values, odds ratios, hazard ratios, 95%
confidence intervals (CIs), and log-rank statistics were
estimated to describe 30-day and long-term mortality.
Kaplan-Meier plots were used to describe unadjusted
survival in patients who underwent concomitant CABG
compared to those who did not and in patients with
unicuspid or bicuspid valves compared to those with
ent isolated aortic valve replacement for aortic stenosis (n  871)
Coronary Artery Bypass Grafting
Yes
28 [49%])
No
(n  443 [51%])
p
Value
0.001
2 (3%) 54 (12%)
9 (32%) 201 (45%)
7 (65%) 188 (42%)
0.001
9 (68%) 233 (53%)
9 (32%) 210 (47%)
0.953
4 (83%) 367 (83%)
4 (6%) 22 (5%)
6 (4%) 19 (4%)
4 (8%) 35 (8%)
 205) (n  272) 0.001
2 (16%)* 246 (90%)
0 (29%) 20 (7%)
8 (33%) 5 (2%)
4 (17%) 1 (1%)
1 (5%) 0
(46) [41] 11–154 (54) [52] 0.001
 0.31 0.76  0.25 0.008
0.001
1 (3%) 49 (11%)
2 (33%) 243 (55%)
5 (64%) 151 (34%)
0.001
(2.89) [2.71] 1.19–7.15 (3.47) [3.28]
8 (3.11) [2.62] 0.81–9.68 (3.11) [2.91]
(2.00) [1.84] 0.55–5.63 (2.11) [1.98]
4 (76%) 292 (66%) 0.015
0.872
8 (35%) 140 (32%)
6 (37%) 136 (31%)
4 (24%) 141 (32%)
8 (4%) 22 (5%)
28  6) 15–61 (29  6)
10) [8] 3–71 (8) [6] 0.001
7 (7%) 18/437 (4%) 0.179
1 (3%) 26 (6%) 0.159
0.001
4 (16%) 140 (32%)
5 (84%) 289 (67%)
1 (1%) 6 (1%)
artery.underw
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1336 The American Journal of Cardiology (www.ajconline.org)A propensity score approach was used to assess the
adjusted association between undergoing concomitant
CABG (vs not) and 30-day and long-term mortality.1,2 To
estimate the propensity score, we used a logistic regres-
sion model with receiving concomitant CABG (vs not) as
the dependent variable and age, gender, race, body mass
index, aortic valve structure, valve weight, systemic hy-
pertension, ascending aorta replaced, and type of im-
planted valve as independent variables. Restricted cubic
splines were used for all continuous variables.3,4 Multiple
imputation via predictive mean matching was used to
account for missing data regarding the independent vari-
ables in this model.1 Estimates from the aforementioned
ropensity model were then used to adjust the effect of
oncomitant CABG on 30-day mortality in a logistic
egression model and on long-term mortality in a Cox
roportional-hazards model. Possible effect modification
y gender and age was investigated for the 2 models and
uled out. The Grambsch and Therneau test statistic was
sed to test for proportionality of hazards in the Cox
odel.5
Figure 1. Photographs of operatively excised stenotic aortic valves in 4
atient. (B) Congenitally bicuspid valve in an 81-year-old man. (C) Co
79-year-old woman. CABG was performed also in patients whose valv
C), and 2.71 g (D).The same approach, controlling for the same con-founding factors except that valve structure was replaced
by concomitant CABG, was used to assess the adjusted
association between valve structure (unicuspid or bicus-
pid vs tricuspid valve structure) and 30-day and long-
term mortality.
Statistical analyses were performed using SAS version
9.2 (SAS Institute Inc., Cary, North Carolina) and R soft-
ware version 2.12.1 (R Project for Statistical Computing,
Vienna, Austria).
Results
Demographic, clinical, and morphologic findings in
the 871 patients included in the present study and their
comparison between those with versus without concom-
itant CABG are listed in Table 1. Of the 871 patients, 428
(49%) underwent concomitant CABG, and 443 (51%) did
not. In comparison to the group that did not undergo
CABG, those who underwent concomitant CABG were
significantly older, were more often male, had lower
transvalvular peak systolic pressure gradients and larger
ts. (A) Congenitally unicuspid unicommissural valve in a 66-year-old
lly bicuspid valve in a 58-year-old man. (D) Tricuspid aortic valve in
hown in (B) and (D). Valve weights were 2.48 g (A), 3.55 g (B), 3.19 gpatien
ngenita
es are svalve areas, had higher frequencies of tricuspid aortic
d
w
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1337Valvular Heart Disease/Aortic Stenosis  Coronary Diseasevalves and lower frequencies of congenitally malformed
aortic valves (Figure 1), had lighter aortic valves by
weight, had higher frequencies of systemic hypertension,
and had longer stays in the hospital after AVR (Table 1).
Unadjusted early mortality (30 days) was not signifi-
cantly (odds ratio 1.59, 95% CI 0.89 to 2.85) different
between those who underwent (29 deaths [7%]) and those
who did not undergo (18 deaths [4%]) simultaneous
CABG. The length of stay for patients surviving 30
ays and long-term survival (up to 10-year follow-up)
ere significantly higher in those who underwent con-
omitant CABG (median length of stay 8 days vs 6 days
Figure 2. Unadjusted (Kaplan-Meier) curves depicting the probability of l
undergo concomitant coronary artery bypass grafting with the aortic valve
p  0.005).
Figure 3. Adjusted (proportional-hazards model) curves depicting no signi
who did not undergo concomitant coronary artery bypass grafting. The prop
mass index, aortic valve structure, valve weight, systemic hypertension, a
95% CI 0.74 to 1.34, adjusted p  0.976).or patients who did not undergo concomitant CABG, p 0.001; unadjusted hazard ratio for survival 1.46, 95%
CI 1.12 to 1.91, log-rank p  0.005). The unadjusted
survival curves are depicted in Figure 2. However, after
adjustment for possible confounders (age, gender, race,
body mass index, aortic valve structure, valve weight,
systemic hypertension, ascending aorta replaced, and
type of implanted valve), neither early mortality (30
days; adjusted odds ratio 1.69, 95% CI 0.87 to 3.29) nor
long-term mortality (10-year follow-up; adjusted hazard
ratio 1.01, 95% CI 0.74 to 1.34) was different between
those who did and did not undergo simultaneous CABG.
The adjusted long-term survival curves are depicted in
m survival in the patients who underwent compared to those who did not
d for stenosis (unadjusted hazard ratio 1.46, 95% CI 1.12 to 1.91, log-rank
ifference in long-term survival in those who underwent compared to those
adjusted model included the following risk factors: age, gender, race, body
g aorta replaced, and type of implanted valve (adjusted hazard ratio 1.01,ong-ter
replaceficant d
ensity-
scendinFigure 3.
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1338 The American Journal of Cardiology (www.ajconline.org)The valve structure in the 871 patients is listed in
Table 2. The 426 patients (49%) with tricuspid aortic
valves, compared to the 445 patients (51%) with either
congenitally unicuspid or bicuspid valves, were signifi-
cantly older (p 0.001), had much higher frequencies of
concomitant CABG (p 0.001), had higher likelihoods
f having 1 major epicardial coronary artery being
arrowed 50% in diameter on angiogram (p 0.001),
had lower transvalvular peak systolic pressure gradients
(p 0.001), had lighter aortic valves by weight (p
0.001), had higher frequencies of systemic hyperten-
sion (p 0.001), had more days in the hospital after AVR
(p 0.001), and had higher late (30 days) mortality
rates after AVR. Unadjusted early mortality (30 days)
was not significantly (odds ratio 1.16, 95% CI 0.56 to
2.42) different between patients with unicuspid or bicus-
Table 2
Comparison of aortic valve structure in patients who underwent isolated a
coronary artery bypass grafting (n  871)
Variable
Unicuspi
(n  60 [7
Age group (years)
21–50 31 (52%
51–70 24 (40%
71–95 5 (8%)
Gender
Male 36 (60%
Female 24 (40%
ace
White 47 (78%
Black 2 (3%)
Hispanic 4 (7%)
Other 7 (12%
oronary artery bypass grafting 11 (18%
umber of major coronary arteries narrowed 50% (n  29
0 23 (79%
1 3 (10%
2 2 (7%)
3 1 (3%)
4 0
V-aorta peak systolic gradient (mm Hg) (n 
475), range (mean) [median]
20–154 (64) [
ortic valve area (cm2) (n  474), mean  SD 0.80  0.3
ortic valve weight (g), range (mean) [median] 1.19–7.15 (3.37
ystemic hypertension by history 27 (45%
ody mass index (kg/m2)
25 24 (41%
25–30 21 (36%
30–40 13 (22%
40 1 (2%)
Range (mean  SD) 17–44 (27 
ays in hospital postoperatively in patients living
30 days, range (mean) [median]
3–32 (7) [6]
ied 30 days postoperatively 0/59
scending aorta replaced 9 (15%
mplanted valve type
Mechanical 41 (68%
Bioprosthetic 17 (28%
Ross procedure 2 (3%)pid versus tricuspid valves. Both unadjusted and adjustedsurvival, however, were significantly higher in patients
with unicuspid or bicuspid valves compared to patients
with tricuspid aortic valves (adjusted hazard ratio 0.70,
95% CI 0.50 to 0.97; Figures 4 and 5).
Coronary angiographic data were available for 477 of the
871 patients (55%). Compared to the 278 patients (58%) in
whom none of the major coronary arteries was narrowed to
this degree, the 199 patients (42%) with 1 coronary artery
narrowed 50% were significantly older (p  0.012), were
more often male (p  0.005), had much higher frequencies
of concomitant CABG (p 0.001), had smaller peak sys-
tolic transvalvular pressure gradients (p  0.010) and larger
valve areas (p  0.002), had higher frequencies of tricuspid
aortic valves and lower frequencies of congenitally mal-
formed valves (p 0.001), and had smaller aortic valves by
alve replacement for aortic stenosis with or without concomitant
Aortic Valve Structure p
Value
Bicuspid
(n  385 [44%])
Tricuspid
(n  426 [49%])
0.001
29 (8%) 6 (1%)
206 (54%) 110 (26%)
150 (39%) 310 (73%)
0.169
252 (65%) 234 (55%)
133 (35%) 192 (45%)
0.274
324 (84%) 350 (82%)
12 (3%) 32 (8%)
18 (5%) 13 (3%)
31 (8%) 31 (7%)
142 (37%) 275 (65%) 0.001
(n  212) (n  236) 0.001
143 (67%) 102 (43%)
34 (16%) 52 (22%)
23 (11%) 49 (21%)
8 (4%) 26 (11%)
4 (2%) 7 (3%)
11–130 (55) [51] 11–119 (45) [41] 0.001
0.78  0.25 0.83  0.30 0.139
0.67–18.38 (3.11) [2.79] 0.43–6.40 (2.04) [1.92] 0.001
260 (68%) 329 (77%) 0.001
0.863
119 (31%) 145 (34%)
130 (34%) 141 (33%)
111 (29%) 121 (29%)
22 (6%) 17 (4%)
16–66 (29  7) 15–69 (29  6)
3–43 (8) [6] 3–71 (10) [8] 0.001
20/380 (5%) 27/425 (6%) 0.222
25 (6%) 3 (1%) 0.001
0.001
118 (31%) 53 (12%)
264 (69%) 371 (87%)
3 (1%) 2 (1%)ortic v
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The present study of patients who underwent AVR for
AS (with or without aortic regurgitation) examined
whether simultaneous CABG (vs not) and aortic valve
structure (unicuspid or bicuspid vs tricuspid) affected
short- and long-term survival. Although the patients who
underwent simultaneous CABG compared to those who
did not were significantly older, were more often male,
had smaller transvalvular peak systolic pressure gradients
and larger valve areas, most often had tricuspid aortic
valves and much less frequently congenitally malformed
valves, had higher frequencies of systemic hypertension,
and had longer hospital stays, the adjusted probability of
long-term survival was no different in those with versus
Figure 4. Unadjusted (proportional-hazards model) curves depicting s
ompared to those with tricuspid valves, all of whom underwent AVR
Figure 5. Adjusted (proportional-hazards model) curves depicting significa
to those with tricuspid valves, all of whom underwent AVR (adjusted haza
model included the following risk factors: age, gender, race, body mass i
replaced, and type of implanted valve.without concomitant CABG. The unadjusted p value re- ogarding the association between concomitant CABG (vs
not) and long-term survival was 0.005, while the adjusted
p value was 0.976.
None of the previously published reports of patients
who underwent AVR for AS with or without simultane-
ous CABG focused on the structure of stenotic aortic
valve.6 –13 In the present study, aortic valve structure was
etermined by the same investigator (W.C.R.) from ex-
mination of the operatively excised valve. We found in
previous study that congruence between cardiac sur-
eons and cardiac pathologists regarding aortic valve
tructure is virtually 100% when the structure of the
ortic valve is tricuspid but that it is only 56% in the case
f congenitally bicuspid valves and only 15% in the case
ntly different survival in patients with unicuspid or bicuspid valves
usted hazard ratio 0.43, 95% CI 0.32 to 0.57, unadjusted p 0.001).
ferent survival in those with unicuspid or bicuspid aortic valves compared
0.70, 95% CI 0.50 to 0.97, adjusted p  0.031). The propensity-adjusted
oncomitant CABG, valve weight, systemic hypertension, ascending aortaignificantly dif
rd ratio
ndex, cf unicuspid valves.14 Thus, uniformity of determination
11340 The American Journal of Cardiology (www.ajconline.org)of valve structure results in far more accurate information
compared to valve structure determined by several dif-
ferent surgeons, each of whom may have varying exper-
tise in describing aortic valve structure or even mention-
ing valve structure in the operative note. Additionally,
the intervals between AVR and dictation of the operative
note were quite variable among surgeons, whose memo-
ries also might be quite variable.14 The present study
found that among the 426 patients with tricuspid aortic
valves, 65% underwent concomitant CABG, whereas
among the 60 patients with unicuspid valves and the 385
with congenitally bicuspid valves, concomitant CABG
was far less frequently performed (18% and 37%, respec-
tively). Both unadjusted and adjusted survival was sig-
nificantly better in the patients with unicuspid or bicuspid
aortic valves compared to those with tricuspid aortic
valves.
A bit surprising to many students of aortic valve disease
was the relatively high frequency of the congenitally mal-
formed valves in all 3 age groups examined. Among the 66
patients aged 21 to 50 years, 60 (91%) had congenitally
malformed aortic valves (unicuspid in 31 and bicuspid in
29); of the 340 patients aged 51 to 70 years, 230 (68%) had
congenitally malformed valves (unicuspid in 24 and bicus-
pid in 206); and of the 465 patients aged 71 to 95 years, 155
(33%) had congenitally malformed valves (unicuspid in 5
and bicuspid in 150).
That CABG was significantly more frequent in the
group with tricuspid aortic valves partly supports the
view that AS in older patients with tricuspid aortic valves
is the result of “atherosclerosis” involving the aortic
valve. Patients with rheumatic heart disease were pre-
sumably excluded from the present study on the basis of
having excluded all patients with mitral stenosis and
those who underwent any operative procedure on the
mitral valve (either repair or replacement).
There were limitations to the present study. Echocar-
diographic and hemodynamic data were not available in
all patients. Not all patients with narrowing 50% in
diameter of 1 major coronary artery underwent CABG.
Many patients who underwent concomitant CABG and
AVR would not have undergone AVR unless 1 of the
coronary arteries had not been quite narrowed by preop-
erative angiogram. A major strength of the present studyis that it is the first to compare long-term survival after
AVR for AS (with or without aortic regurgitation) ac-
cording to the underlying valve structure (unicuspid, bi-
cuspid, or tricuspid).
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